Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
CGON on Nasdaq
There are no Buy or Sell transactions made by Decheng Capital Global Life Sciences Fund IV, L.P. since 12/22/2023
Holdings reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4.96M |
$175M |
$35.36 |
Jan 29, 2024 |
Direct |
|
|
| Series C Preferred Stock |
0 |
|
|
Jan 29, 2024 |
Direct |
Common Stock |
|
| Series E Preferred Stock |
0 |
|
|
Jan 29, 2024 |
Direct |
Common Stock |
|
| Series F Preferred Stock |
0 |
|
|
Jan 29, 2024 |
Direct |
Common Stock |
|
Transactions reported by Decheng Capital Global Life Sciences Fund IV, L.P. for CG Oncology, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.